456408 Consumner Co-Payments for Subsidised Medicines: Impact on Access and Health Outcomes

Roughead, Elizabeth (Chief Investigator)
Semmens, James (Investigator 02)
Preen, David (Investigator 03)
Glover, John (Investigator 04)

Project Details

Status	Finished
Effective start/end date	31/12/06 → 31/12/10

Funding

National Health & Medical Research Council NHMRC: AUD95,500.00
National Health & Medical Research Council NHMRC: AUD108,500.00
National Health & Medical Research Council NHMRC: AUD128,668.00
National Health & Medical Research Council NHMRC: AUD96,000.00

3 Article

Frequent general practitioner visits are protective against statin discontinuation after a Pharmaceutical Benefits Scheme copayment increase
Seaman, K. L., Sanfilippo, F. M., Bulsara, M. K., Brett, T., Kemp-Casey, A., Roughead, E. E., Bulsara, C. & Preen, D. B., Jun 2020, In : Australian Health Review. 44, 3, p. 377-384 8 p.
Research output: Contribution to journal › Article
Increased risk of 2-year death in patients who discontinued their use of statins
Seaman, K., Sanfilippo, F., Bulsara, M., Roughead, E., Kemp-Casey, A., Bulsara, C., Watts, G. F. & Preen, D., 18 Nov 2020, In : PUNISHMENT & SOCIETY-INTERNATIONAL JOURNAL OF PENOLOGY. 11 p.
Research output: Contribution to journal › Article
Predictors of ceasing or reducing statin medication following a large increase in the consumer copayment for medications: a retrospective observational study
Seamon, K., Sanfilippo, F., Bulsara, M., Roughead, L., Kemp-Casey, A., Bulsara, C., Watts, G. F. & Preen, D., 10 Mar 2020, In : Public Health Research & Practice. 30, 1
Research output: Contribution to journal › Article

Open Access